Edwards Lifesciences Corporation (NYSE: EW) announced that the randomized PARTNER II Trial comparing the SAPIEN XT valve to surgery in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE